Literature DB >> 15474354

Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.

C Grothe1, M Timmer, T Scholz, C Winkler, G Nikkhah, P Claus, N Itoh, E Arenas.   

Abstract

Stem cells are currently considered as alternative cell resources for restorative transplantation strategies in Parkinson's disease. However, the mechanisms that induce differentiation of a stem cell toward the dopaminergic phenotype are still partly unknown thus hampering the production of dopaminergic neurons from stem cells. In the past, FGF-20 has been found to promote the survival of ventral mesencephalic (VM) dopaminergic (DA) neurons in culture. We hereby provide evidence that FGF-20, a growth factor of the FGF family, is expressed in the adult and 6-OHDA-lesioned striatum and substantia nigra, but is not expressed by VM glia or DA neurons, suggesting that FGF-20 may work on DA neurons in a paracrine- or target-derived manner. We also found that co-culture of Nurr1-NSCs with Schwann cells overexpressing FGF-20 induced the acquisition of a neuronal morphology by the NSCs and the expression of tyrosine hydroxylase (TH) as assessed by immunocytochemistry, cell ELISA, and Western blot analysis. RT-PCR showed, that both, Schwann cells and Nurr1-NSCs (differentiated or not), expressed the FGF-1 receptor suggesting that both direct and indirect actions of FGF-20 are possible. We show that differentiated Nurr1 cells retained both neuronal morphology and TH expression after transplantation into the striatum of 6-OHDA-lesioned postnatal or adult rats, but that neuritogenesis was only observed after postnatal grafts. Thus, our results suggest that FGF-20 promotes the differentiation of Nurr1-NSCs into TH-positive neurons and that additional factors are required for the efficient differentiation of DA neurons in the adult brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474354     DOI: 10.1016/j.nbd.2004.07.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

1.  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

2.  Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion.

Authors:  Marco Timmer; Konstantin Cesnulevicius; Christian Winkler; Julia Kolb; Esther Lipokatic-Takacs; Julia Jungnickel; Claudia Grothe
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

3.  FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system.

Authors:  Andreas Ratzka; Olga Baron; Claudia Grothe
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

4.  Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.

Authors:  Edward J R Fletcher; Aran D Jamieson; Gareth Williams; Patrick Doherty; Susan Duty
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

5.  Roles of FGF20 in dopaminergic neurons and Parkinson's disease.

Authors:  Nobuyuki Itoh; Hiroya Ohta
Journal:  Front Mol Neurosci       Date:  2013-05-31       Impact factor: 5.639

6.  Identification of multiple subsets of ventral interneurons and differential distribution along the rostrocaudal axis of the developing spinal cord.

Authors:  Cédric Francius; Audrey Harris; Vincent Rucchin; Timothy J Hendricks; Floor J Stam; Melissa Barber; Dorota Kurek; Frank G Grosveld; Alessandra Pierani; Martyn Goulding; Frédéric Clotman
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

7.  Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.

Authors:  Ana Sofia Correia; Sergey V Anisimov; Laurent Roybon; Jia-Yi Li; Patrik Brundin
Journal:  Front Neuroanat       Date:  2007-12-30       Impact factor: 3.856

8.  Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.

Authors:  Ana Sofia Correia; Sergey V Anisimov; Jia-Yi Li; Patrik Brundin
Journal:  Front Neurosci       Date:  2008-07-07       Impact factor: 4.677

9.  Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.

Authors:  Eugene L Boshoff; Edward J R Fletcher; Susan Duty
Journal:  Neuropharmacology       Date:  2018-04-23       Impact factor: 5.250

10.  Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.

Authors:  Jianlou Niu; Junjun Xie; Kaiwen Guo; Xiaomin Zhang; Feng Xia; Xinyu Zhao; Lintao Song; Deli Zhuge; Xiaokun Li; Yingzheng Zhao; Zhifeng Huang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.